Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 15  •  04:00PM ET
73.46
Dollar change
-1.52
Percentage change
-2.03
%
IndexS&P 500 P/E20.50 EPS (ttm)3.58 Insider Own0.15% Shs Outstand1.27B Perf Week4.55%
Market Cap93.17B Forward P/E10.27 EPS next Y7.16 Insider Trans-66.38% Shs Float1.27B Perf Month10.09%
Enterprise Value161.85B PEG1.43 EPS next Q1.36 Inst Own87.67% Short Float1.48% Perf Quarter8.89%
Income4.53B P/S0.24 EPS this Y17.08% Inst Trans1.10% Short Ratio2.44 Perf Half Y11.85%
Sales386.46B P/B1.20 EPS next Y12.76% ROA1.77% Short Interest18.80M Perf YTD63.64%
Book/sh61.07 P/C6.55 EPS next 5Y14.33% ROE5.95% 52W High75.55 -2.77% Perf Year30.92%
Cash/sh11.21 P/FCF19.49 EPS past 3/5Y-14.99% -6.37% ROIC3.04% 52W Low43.56 68.64% Perf 3Y-28.16%
Dividend Est.2.64 (3.60%) EV/EBITDA9.96 Sales past 3/5Y8.48% 7.75% Gross Margin13.78% Volatility2.69% 2.18% Perf 5Y23.40%
Dividend TTM2.66 (3.62%) EV/Sales0.42 EPS Y/Y TTM-36.28% Oper. Margin3.01% ATR (14)1.78 Perf 10Y-26.63%
Dividend Ex-DateJul 22, 2025 Quick Ratio0.62 Sales Y/Y TTM6.27% Profit Margin1.17% RSI (14)60.04 Recom1.55
Dividend Gr. 3/5Y9.07% 5.87% Current Ratio0.80 EPS Q/Q-42.82% SMA201.42% Beta0.61 Target Price81.48
Payout72.76% Debt/Eq1.07 Sales Q/Q8.34% SMA509.43% Rel Volume0.91 Prev Close74.98
Employees300000 LT Debt/Eq0.93 EarningsJul 31 BMO SMA20017.57% Avg Volume7.69M Price73.46
IPOOct 01, 1952 Option/ShortYes / Yes EPS/Sales Surpr.24.14% 4.64% Trades Volume6,961,999 Change-2.03%
Date Action Analyst Rating Change Price Target Change
Aug-18-25Upgrade UBS Neutral → Buy $79
Aug-14-25Upgrade Robert W. Baird Neutral → Outperform $82
Feb-13-25Upgrade Leerink Partners Market Perform → Outperform $55 → $75
Feb-12-25Upgrade Cantor Fitzgerald Neutral → Overweight
Jan-30-25Upgrade Edward Jones Hold → Buy
Dec-03-24Upgrade Deutsche Bank Hold → Buy $66
Nov-18-24Upgrade Wells Fargo Equal Weight → Overweight $60 → $66
Oct-10-24Upgrade Barclays Equal Weight → Overweight $63 → $82
Oct-04-24Upgrade TD Cowen Hold → Buy $59 → $85
May-30-24Initiated Robert W. Baird Neutral $61
Today 01:48PM
05:05AM
Sep-13-25 01:49PM
Sep-12-25 05:37AM
Sep-11-25 01:01PM
11:52AM Loading…
11:52AM
09:00AM
08:22AM
Sep-10-25 10:29AM
09:25AM
09:00AM
09:00AM
Sep-09-25 04:49PM
04:30PM
01:38PM
09:50AM Loading…
09:50AM
09:30AM
Sep-08-25 06:12PM
05:34PM
03:36PM
01:10PM
11:26AM
08:39AM
06:05AM
Sep-04-25 08:35AM
04:41AM
Sep-03-25 08:30AM
Sep-02-25 11:24AM
08:38AM
06:38AM
09:40AM Loading…
Sep-01-25 09:40AM
09:15AM
04:00AM
Aug-31-25 12:10AM
Aug-29-25 09:00AM
Aug-28-25 11:57PM
05:59PM
Aug-27-25 11:40AM
09:21AM
Aug-26-25 09:40AM
08:30AM
Aug-25-25 08:49PM
08:49PM
Aug-22-25 09:55AM
08:39AM
05:57AM
05:04AM
Aug-21-25 12:15PM
11:00AM
10:39AM
10:21AM
09:20AM
08:50AM
08:06AM
Aug-20-25 04:41PM
10:06AM
09:30AM
06:00AM
Aug-18-25 04:25PM
02:32PM
09:33AM
09:06AM
09:00AM
09:00AM
09:00AM
Aug-17-25 05:07PM
Aug-15-25 12:27PM
11:12AM
10:16AM
Aug-14-25 09:41AM
09:40AM
09:40AM
08:30AM
Aug-13-25 06:03PM
12:06AM
12:05AM
Aug-12-25 08:48AM
07:00AM
Aug-11-25 03:57PM
11:40AM
12:01AM
Aug-09-25 10:48AM
Aug-07-25 07:23PM
03:00PM
07:56AM
Aug-06-25 03:27PM
10:30AM
09:00AM
06:47AM
06:42AM
04:45AM
Aug-05-25 11:00AM
10:52AM
10:19AM
09:00AM
08:19AM
05:30AM
Aug-04-25 07:30PM
01:19PM
09:37AM
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Finucane Anne A.DirectorAug 20 '25Sale71.027,500532,65022,156Aug 29 04:29 PM
Finucane Anne A.DirectorAug 20 '25Proposed Sale70.977,500532,275Aug 19 06:57 PM
SANSONE GUY PDirectorJun 05 '25Buy63.701,570100,00912,007Jun 09 08:22 AM
ROBBINS LARRYDirectorMay 02 '25Sale67.862,276,068154,444,7589,670,731May 06 04:15 PM
ROBBINS LARRYDirectorMay 05 '25Sale67.411,323,93289,249,9458,346,799May 06 04:15 PM
ROBBINS LARRYDirectorMay 06 '25Sale66.67150,00010,000,7108,196,799May 06 04:15 PM
Shah Prem SEVP and Group PresidentMar 17 '25Option Exercise62.2184652,63043,190Mar 18 04:51 PM
Clark James DavidSVP, Cont & Chief Acct OfficerMar 05 '25Option Exercise62.217,513467,38415,907Mar 07 04:56 PM
Clark James DavidSVP, Cont & Chief Acct OfficerMar 05 '25Sale66.357,513498,4888,394Mar 07 04:56 PM
Clark James DavidOfficerMar 05 '25Proposed Sale66.357,513498,489Mar 05 05:25 PM
Mahoney Michael FDirectorFeb 18 '25Buy66.7030,0002,001,00039,356Feb 19 12:35 PM